Spherix Research Reveals Rheumatologists Taking the Lead Over Nephrologists in Both BENLYSTA (GlaxoSmithKline) and LUPKYNIS (Aurinia) Patient Initiations in Lupus Nephritis

Nephrologists and rheumatologists are approaching the new products from very different perspectives EXTON, Pa. , June 17, 2022 /PRNewswire/ — With the approvals of GlaxoSmithKline’s Benlysta in lupus nephritis (LN) at the end of 2020 and Aurinia’s Lupkynis at the beginning of 2021,…

Click here to view original post

Be the first to comment

Leave a Reply

Your email address will not be published.